X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB PFIZER UNICHEM LAB/
PFIZER
 
P/E (TTM) x 22.2 24.0 92.3% View Chart
P/BV x 2.3 3.8 61.1% View Chart
Dividend Yield % 0.8 0.8 95.9%  

Financials

 UNICHEM LAB   PFIZER
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
PFIZER
Mar-16
UNICHEM LAB/
PFIZER
5-Yr Chart
Click to enlarge
High Rs3342,724 12.3%   
Low Rs1741,611 10.8%   
Sales per share (Unadj.) Rs146.9440.9 33.3%  
Earnings per share (Unadj.) Rs11.948.7 24.4%  
Cash flow per share (Unadj.) Rs16.275.8 21.4%  
Dividends per share (Unadj.) Rs2.0015.00 13.3%  
Dividend yield (eoy) %0.80.7 113.8%  
Book value per share (Unadj.) Rs105.1462.9 22.7%  
Shares outstanding (eoy) m90.8445.75 198.6%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.74.9 35.2%   
Avg P/E ratio x21.444.5 48.0%  
P/CF ratio (eoy) x15.728.6 54.9%  
Price / Book Value ratio x2.44.7 51.6%  
Dividend payout %16.830.8 54.6%   
Avg Mkt Cap Rs m23,07399,163 23.3%   
No. of employees `0005.72.9 196.4%   
Total wages/salary Rs m2,5582,758 92.8%   
Avg. sales/employee Rs Th2,352.56,981.7 33.7%   
Avg. wages/employee Rs Th450.9954.5 47.2%   
Avg. net profit/employee Rs Th190.4771.1 24.7%   
INCOME DATA
Net Sales Rs m13,34620,170 66.2%  
Other income Rs m192857 22.4%   
Total revenues Rs m13,53821,028 64.4%   
Gross profit Rs m1,6394,310 38.0%  
Depreciation Rs m3901,239 31.5%   
Interest Rs m295 553.8%   
Profit before tax Rs m1,4123,923 36.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-3599 -35.7%   
Tax Rs m2931,794 16.3%   
Profit after tax Rs m1,0802,228 48.5%  
Gross profit margin %12.321.4 57.5%  
Effective tax rate %20.745.7 45.3%   
Net profit margin %8.111.0 73.3%  
BALANCE SHEET DATA
Current assets Rs m5,97916,299 36.7%   
Current liabilities Rs m2,4327,594 32.0%   
Net working cap to sales %26.643.2 61.6%  
Current ratio x2.52.1 114.6%  
Inventory Days Days6365 96.6%  
Debtors Days Days6026 234.5%  
Net fixed assets Rs m6,4038,622 74.3%   
Share capital Rs m182458 39.7%   
"Free" reserves Rs m9,29320,722 44.8%   
Net worth Rs m9,54821,180 45.1%   
Long term debt Rs m23025 921.6%   
Total assets Rs m12,84329,137 44.1%  
Interest coverage x50.0755.5 6.6%   
Debt to equity ratio x00 2,044.3%  
Sales to assets ratio x1.00.7 150.1%   
Return on assets %8.67.7 112.7%  
Return on equity %11.310.5 107.6%  
Return on capital %14.319.0 75.5%  
Exports to sales %29.20.1 49,114.6%   
Imports to sales %6.317.5 36.3%   
Exports (fob) Rs m3,90012 32,496.7%   
Imports (cif) Rs m8473,526 24.0%   
Fx inflow Rs m4,35652 8,434.5%   
Fx outflow Rs m1,162140 830.3%   
Net fx Rs m3,194-88 -3,616.1%   
CASH FLOW
From Operations Rs m1,1193,436 32.6%  
From Investments Rs m-853-6,991 12.2%  
From Financial Activity Rs m-334-619 54.0%  
Net Cashflow Rs m-68-4,174 1.6%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 15.1 7.5 201.3%  
FIIs % 3.0 4.9 61.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 23.7 133.8%  
Shareholders   20,176 85,207 23.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   DIVIS LABORATORIES  WOCKHARDT LTD.  AUROBINDO PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens 200 Points Higher; Lupin & Axis Bank Top Gainers(09:30 am)

Majority of Asian stock indices are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.07%, while the Hang Seng is up 1.06%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Aug 22, 2017 11:28 AM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS